EXTRAOESOPHAGEAL MANIFESTATIONS OF GASTROESOPHAGEAL REFLUX DISEASE IN THE PRACTICE OF PEDIATRIC OTORHINOLARYNGOLOGIST
https://doi.org/10.21508/1027-4065-2017-62-6-87-91
Abstract
Gastroesophageal reflux disease (GERD) is a chronic recurrent disorder with esophageal and extraesophageal symptoms and a variety of morphological changes of the mucous membrane of the esophagus caused by retrograde reflux of the gastric or gastro-intestinal contents. Extraesophageal (atypical) symptoms are mainly complaints which indicate involvement in the process of bronchopulmonary, cardiovascular diseases and ENT-organs. This article discusses the pathogenesis of extraesophageal manifestations of GERD, and recommendations on diagnosis and treatment based on the author’s own experience and data of international publications.
About the Authors
A. I. Asmanov
Yu.E. Veltischev Clinical Research Institute of Pediatrics, Pirogov Russian National Research Medical University
Russian Federation
Moscow
Russian Federation
Moscow
Z. K. Hanakaeva
Yu.E. Veltischev Clinical Research Institute of Pediatrics, Pirogov Russian National Research Medical University
Russian Federation
Moscow
Russian Federation
Moscow
N. D. Pivneva
Yu.E. Veltischev Clinical Research Institute of Pediatrics, Pirogov Russian National Research Medical University
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Коваленко А.А., Бельмер С.В. Гастроэзофагеальная рефлюксная болезнь. Лечащий Врач 2008; 1: 14–18. [Kovalenko A.A., Bel’mer Gastroesophageal S.V. reflux disease. Lechashhij Vrach 2008; 1: 14–18. (in Russ)]
2. Строзенко Л.А., Лобанов Ю.Ф. Клиническая характеристика эрозивного гастродуоденита у детей. Современные проблемы науки и образования 2012; 1; 61. [Strozenko L.A., Lobanov Yu.F. Clinical feature erosive gastroduodenitis at children. Sovremennye problemy nauki i obrazovania 2012; 1; 61. (in Russ)]
3. Van Soest E.M., Dieleman J.P., Siersema P.D., Sturkenboom M.C., Kuipers E.J. Increasing incidence of Barrett’s oesophagus in the general population. J Pediatr Gastroenterol Nutr 2005; 54 (8): 1062–1066. DOI: 10.1136/gut.2004.063685
4. Vandenplas Y., Rudolph С.D., Di Lorenzo C., Hassall E., LiptakG., Mazur L. et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009; 49: 498–547. DOI: 10.1097/MPG.0b013e3181b7f563
5. Malfertheiner P., Megraud F., O’Morain С.A., Atherton J., Ахоп А.Т., Bazzoli F., Gensini G.F., Gisbert J.P, Graham D.Y., Rokkas Т., El-Omar E.M., Kuipers E.J. European Helicobacter Study Group. Management of Helicobacter pylori infection. The Maastricht IV/Florence Consensus Report 2012; 61 (5): 646–664.
6. Борисов А.С., Кондратьева И.В., Цуканова Е.С. Гастроэзофагеальная рефлюксная болезнь у детей и подростков. Прикладные информационные аспекты медицины 2017; 20 (3): 40–44. [Borisov A.S., Kondrat’eva I.V., Cukanova E.S. Gastroesophageal reflux disease in children and teens. Prikladnye informacionnye aspekty meditsiny. 2017; 20 (3): 40–44. (in Russ)]
7. Апеченко Ю.С., Червинец В.М., Иванова И.И., Басалаева Н.В., Беляева Е.А. Микробиоценоз верхних отделов пищеварительного тракта у детей с гастроэзофагеальной рефлюксной болезнью и хроническим гастродуоденитом. Клиническая лабораторная диагностика. 2013; 4: 40–43. [Apechenko Yu.S., Chervinec V.M., Ivanova I.I., Basalaeva N.V., Belyaeva E.A. Microbiocenosis of the upper digestive tract in children with gastroesophageal reflux disease and chronic gastroduodenitis. Klinicheskaya laboratornaya diagnostika 2013; 4: 40–43. (in Russ)]
8. O’Reilly M, Talsma A, VanRiper S, Kheterpal S, Burney R. An anesthesia information system designed to provide physicianspecific feedback improves timely administration of prophylactic antibiotics. Anesth Analg 2008; 103 (4): 908–912. DOI: 10.1213/01.ane.0000237272.77090.a2
9. Campos G.M., Peters J.K, DeMeester T.R., Oberg S., Crookes P.F, Mason R.J. The pattern of esophageal acid exposure in gastroesophageal reflux disease influences the severity of the disease. Arch Surg 1999; 134 (8): 882–887.
10. Kongara K., Varitek G., Soffer E.E. Salivary growth factors and cytokines are not deficient in patients with GERD or Barretts esophagus. Dig Dis Sci 2001; 46 (3): 606–609.
11. Карпова Е.П., Тулупов Д.А., Завикторина Т.Г. Изменение микрофлоры глоточной миндалины у детей с хроническим адсноидитом, ассоциированным с гастроэзофагеальной рефлюксной болезнью. Российская ринология 2009; 2: 61. [Karpova E.P., Tulupov D.A., Zaviktorina T.G. Сhanges of the microflora of palatine tonsils in children with chronic adenoiditis associated with gastroesophageal reflux disease. Rossiiskaya rinologija 2009; 2: 61. (in Russ)]
12. Карпычева И.Е., Тулупов Д.А., Карпова Е.П. Возможности оральных пробиотиков в профилактике хронического аденоидита у детей. Медицинский совет 2015; 6: 94–100. DOI:10.21518/2079-701X-2015-6-94-100 [Karpycheva I.E., Tulupov D.A., Karpova E.P. Options for oral probiotics in the prevention of chronic adenoiditis in children. Medicinsky Sovet 2015; 6: 94–100. DOI:10.21518/2079701X-2015-6-94-100 (in Russ)]
13. Koufman J.A., Dettmar P.W., Johnston N. Laryngopharyngeal Reflux (LPR). ENT NEWS 2005; 14 (1): 42–45.
14. Merati A.L., Lim H.J., Ulualp S.O. Metaanalysis of upper probe measurements in normal subjects and patients with laryngopharyngeal reflux. Ann Otol Rhinol Laryngol 2005; 114: 177–182. DOI:10.1177/000348940511400302
15. Vaezi M.F., Slaughter J.C., Smith B.S., Washington M.K., Jerome W.G., Garrett C.G. et al. Dilated intercellular space in chronic laryngitis and gastro-oesophageal reflux dis ease: at baseline and post-lansoprazole therapy. Aliment Pharmacol Ther 2010; 32: 916–924. DOI: 10.1111/j.13652036.2010.04420.x
16. Vaezi M.F. Laryngitis: from the gastroenterologist’s point of view. In: Extraesophageal Reflux. Vaezi M.F. (ed.). San Diego, Calif: Plural Publishing, Inc, 2009; 37–47.
17. Pritchett J.M., Aslam M., Slaughter J.C., Ness R.M., Garrett C.G., Vaezi M.F. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol 2009; 7: 743–748. DOI: 10.1016/j.cgh.2009.02.022
18. Fletcher K.C., Goutte M., Slaughter J.C., Garrett C.G., Vaezi M.F. Significance and degree of reflux in patients with primary extraesophageal symptoms. Laryngoscope 2011; 121: 2561–2565. DOI: 10.1002/lary.22384
19. Wiener G.J., Tsukashima R., Kelly C., Wolf E., Schmeltzer M., Bankert C. et al. Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux. J Voice 2009; 23: 498–504. DOI: 10.1016/j.jvoice.2007.12.005
Review
For citations:
Asmanov A.I., Hanakaeva Z.K., Pivneva N.D. EXTRAOESOPHAGEAL MANIFESTATIONS OF GASTROESOPHAGEAL REFLUX DISEASE IN THE PRACTICE OF PEDIATRIC OTORHINOLARYNGOLOGIST. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2017;62(6):87-91. (In Russ.) https://doi.org/10.21508/1027-4065-2017-62-6-87-91
Views:
1281
Email this article 